Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Jones

Showing results (181-190 of 212) with videos related to

Pageof 22
Sort By:
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1986
L-649,923, sodium (beta S*, gamma R*-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propylthio)-gamma-hydroxy -beta-methylbenzenebutanoate. A selective, orally active leukotriene D4 receptor antagonistR N Young, Y Guindon, T R Jones, et al.
Journal of Virology|September 12, 2000
Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 geneM van Zeijl, J Fairhurst, T R Jones, et al.
The Journal of Cell Biology|July 29, 1998
Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potentialD Tortorella, C M Story, J B Huppa, et al.
Journal of Medicinal Chemistry|October 27, 1995
Thiopyranol[2,3,4-c,d]indoles as inhibitors of 5-lipoxygenase, 5-lipoxygenase-activating protein, and leukotriene C4 synthaseJ H Hutchinson, S Charleson, J F Evans, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 6, 2000
A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivoY Guo, A A Higazi, A Arakelian, et al.
Immunology Series|January 1, 1994
Life and death of an intracellular pathogen: Francisella tularensis and the macrophageA H Fortier, S J Green, T Polsinelli, et al.
Nature Medicine|September 2, 1999
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cellsR Tomazin, J Boname, N R Hegde, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Novel arylthio- and arylsulfonylpropyloxyacetophenones: design and synthesis of L-648,051 and L-649,923, potent antagonists of leukotriene D4R N Young, T R Jones, J G Atkinson, et al.
Epidemiology and Infection|March 31, 2009
Risk factors for the occurrence of Escherichia coli virulence genes eae, stx1 and stx2 in wild bird populationsL A Hughes, M Bennett, P Coffey, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of SingulairD Guay, J Y Gauthier, C Dufresne, et al.
Pageof 22

Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1986
L-649,923, sodium (beta S*, gamma R*-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propylthio)-gamma-hydroxy -beta-methylbenzenebutanoate. A selective, orally active leukotriene D4 receptor antagonistR N Young, Y Guindon, T R Jones, et al.
Journal of Virology|September 12, 2000
Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 geneM van Zeijl, J Fairhurst, T R Jones, et al.
The Journal of Cell Biology|July 29, 1998
Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potentialD Tortorella, C M Story, J B Huppa, et al.
Journal of Medicinal Chemistry|October 27, 1995
Thiopyranol[2,3,4-c,d]indoles as inhibitors of 5-lipoxygenase, 5-lipoxygenase-activating protein, and leukotriene C4 synthaseJ H Hutchinson, S Charleson, J F Evans, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 6, 2000
A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivoY Guo, A A Higazi, A Arakelian, et al.
Immunology Series|January 1, 1994
Life and death of an intracellular pathogen: Francisella tularensis and the macrophageA H Fortier, S J Green, T Polsinelli, et al.
Nature Medicine|September 2, 1999
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cellsR Tomazin, J Boname, N R Hegde, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Novel arylthio- and arylsulfonylpropyloxyacetophenones: design and synthesis of L-648,051 and L-649,923, potent antagonists of leukotriene D4R N Young, T R Jones, J G Atkinson, et al.
Epidemiology and Infection|March 31, 2009
Risk factors for the occurrence of Escherichia coli virulence genes eae, stx1 and stx2 in wild bird populationsL A Hughes, M Bennett, P Coffey, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of SingulairD Guay, J Y Gauthier, C Dufresne, et al.
Pageof 22